eznews.in
New research from the University of Birmingham highlights the vascular benefits of flavanol-rich foods, particularly for those who lead sedentary lifestyles. As modern living increasingly involves prolonged sitting—averaging at least six hours daily for many adults—vascular function, especially in the legs, can decline. The study, published in *The Journal of Physiology*, involved 40 healthy young men who consumed either a high-flavanol or low-flavanol cocoa drink before sitting for two hours. Results showed that those who consumed the high-flavanol drink maintained better blood flow in their arteries compared to the low-flavanol group. Experts noted that while flavanols can help counteract the negative effects of sitting, regular movement and exercise remain essential for optimal vascular health. They advise incorporating flavanol-rich foods into a balanced diet while emphasizing that these should complement, not replace, an active lifestyle. 
Published: Nov 04 2025, 11 pmeznews.inA recent study presented at the American Heart Association's Scientific Sessions 2025 suggests that adhering to the AHA's "Life's Essential 8" heart health recommendations may significantly reduce the risk of dementia and mild cognitive impairment (MCI) in individuals with type 2 diabetes. With approximately 589 million adults globally living with diabetes, over 90% of which are type 2 cases, the findings are particularly relevant. Researchers analyzed data from over 35,000 participants and found that those with moderate to high cardiovascular health lowered their MCI and dementia risks by 15%. Notably, participants with high genetic risk for dementia saw a 27% reduction in MCI risk and a 23% reduction in dementia risk. Experts emphasize the importance of lifestyle changes in managing cardiovascular health, suggesting that even small, consistent habits can have a substantial impact on cognitive function, highlighting a hopeful pathway for diabetes management and cognitive health preservation.
Published: Nov 05 2025, 12 ameznews.inA recent study published in the journal *Science Advances* suggests that the blood vessels in the retina could serve as a noninvasive method to predict heart disease risk and biological aging. Researchers found that individuals with simpler, less branched retinal blood vessels exhibited higher chances of developing cardiovascular issues and showed signs of accelerated aging, such as increased inflammation and reduced lifespan. Dr. Marie Pigeyre, the study's lead author, emphasized the potential of retinal imaging to reveal subtle changes linked to heart health and aging. The study also identified specific proteins associated with vascular changes, which could offer new therapeutic targets. Experts, including Dr. Benjamin Bert and Dr. Craig Basman, highlighted the implications of these findings for early diagnosis and proactive health management, noting that while promising, further research is needed to validate these results and refine predictive models.
Published: Nov 04 2025, 12 ameznews.inA recent study published in the journal MSYSTEMS has revealed that various common prescription medications, including antidepressants, beta-blockers, and proton pump inhibitors, may have long-lasting effects on gut health, persisting for years after discontinuation. While antibiotics have long been known to disrupt the gut microbiome by killing beneficial bacteria, this research highlights that other drugs can similarly alter microbiome composition. Researchers analyzed data from over 2,500 adults in Estonia, finding that 167 out of 186 medications assessed impacted the microbiome, with 78 showing enduring effects. Notably, benzodiazepines appeared to have the most significant negative influence. Experts caution that while the study's methodology is robust, it is not a controlled trial, and factors like diet and environment also play a role. They recommend careful medication management and lifestyle choices, such as a high-fiber diet and regular exercise, to support gut health.
Published: Nov 01 2025, 5 pmeznews.inThe Medicare open enrollment period for 2026 runs from October 15 to December 7, 2025, allowing older adults, aged 65 and over, to enroll or modify their plans. Significant changes are anticipated, including higher monthly premiums and out-of-pocket costs for prescription medications. The average monthly premium for Medicare Advantage plans is projected to decrease from $16 in 2025 to $14 in 2026, while stand-alone Part D premiums are expected to drop from $38 to $34. However, some insurance companies may raise Part D premiums by up to $50 monthly. The annual out-of-pocket cap for Medicare Advantage will decrease slightly to $9,250, but the limit for Part D drugs will rise to $2,100. Beneficiaries are encouraged to compare plans to find the best options, especially as the number of stand-alone Part D plans is set to decrease from 464 to 360. Additionally, uncertainties surrounding a potential federal government shutdown could impact services and claims processing.
Published: Nov 01 2025, 12 ameznews.inA new study has shown promising results for a wireless retinal implant, known as the PRIMA system, designed to restore central vision in individuals suffering from geographic atrophy, an advanced form of age-related macular degeneration (AMD). Currently affecting about 8 million people globally, geographic atrophy leads to irreversible vision loss, and there is no cure available. The research involved 38 participants over 60 years old, with 32 completing the trial. Remarkably, 26 of them experienced significant improvements in visual acuity after one year of using the implant and accompanying glasses, with many regaining the ability to read at home. While the implant does not restore full vision, it offers hope for enhancing the quality of life for those affected by AMD. Experts emphasize the need for further studies to evaluate the device's long-term safety and efficacy, noting that improvements in vision can help maintain independence for aging patients.
Published: Oct 30 2025, 5 pmeznews.inA recent study published in the Annals of Internal Medicine has revealed that the duration of walking may significantly impact cardiovascular health and mortality risk. Researchers analyzed data from 33,560 participants in the UK Biobank, all taking 8,000 steps or fewer daily. They found that individuals who accumulated their steps in longer bouts, particularly those lasting 10 minutes or more, had a notably lower risk of cardiovascular disease and all-cause mortality compared to those who walked in shorter intervals. The study highlights that about 43% of participants walked in bouts of less than five minutes, which correlated with higher health risks. While the findings suggest that longer, sustained walking sessions could enhance cardiovascular outcomes, the study's observational nature limits definitive conclusions. Experts advocate for integrating longer walking sessions into daily routines, emphasizing that even modest changes in walking patterns can yield significant health benefits.
Published: Oct 30 2025, 2 ameznews.inA recent study published in *Brain Medicine* reveals that exercise can mitigate some depressive and anxiety-like symptoms linked to high-fat, high-sugar diets typical of Western eating habits. Conducted on rats, the research found that regular physical activity helped normalize levels of metabolic hormones such as insulin and leptin, which were disrupted by unhealthy diets. While exercise reduced weight gain and improved mood, it did not fully counteract all negative effects of a poor diet, emphasizing the importance of a balanced diet alongside physical activity for optimal mental health. The study's lead author, Yvonne Nolan from University College Cork, noted that further research is necessary to confirm these findings in humans, as the results may not directly translate due to differences in physiology. The study highlights the growing concern over the mental health impacts of modern dietary patterns, compounded by sedentary lifestyles.
Published: Oct 29 2025, 12 ameznews.inA new study published in *The Lancet* suggests that GLP-1 receptor agonists, such as semaglutide, may offer heart health benefits beyond weight loss. Previous research indicated that semaglutide could reduce the risk of heart attacks, strokes, and major cardiac events by 20%. The latest findings, based on data from over 17,000 adults with cardiovascular disease, reveal that the reduction in major cardiac events is consistent regardless of weight loss. John Deanfield, the study's lead author, emphasized that semaglutide should not be viewed merely as a weight loss drug, as it may also benefit patients with modest weight or normal BMI. While waist circumference was linked to better heart health outcomes, it accounted for only a third of the cardiovascular benefits, suggesting other biochemical mechanisms at play. Experts call for further research to explore these mechanisms and the broader implications for cardiometabolic disease management.
Published: Oct 28 2025, 12 ameznews.inA new investigational drug, valiltramiprosate (ALZ-801), has shown promising results in a Phase 3 clinical trial for patients genetically predisposed to Alzheimer’s disease, particularly those with two copies of the APOE4 gene variant. This group, which represents about 15% of Alzheimer’s cases, faces heightened risks and limited treatment options. The study, involving 325 participants with mild cognitive impairment (MCI) or early Alzheimer’s, indicated that those treated with ALZ-801 experienced slower brain atrophy and reduced neurodegeneration compared to a placebo group. Although the overall trial did not meet its primary endpoint, a prespecified analysis highlighted significant benefits for MCI patients, including cognitive and functional improvements. Experts expressed cautious optimism about the drug's safety profile, especially in contrast to existing treatments that carry serious side effects. Future studies will be crucial to confirm these findings and assess the drug's potential as a safer alternative for high-risk patients.
Published: Oct 26 2025, 4 pmFor the fastest, latest, not so wokest news, 'experts say' you need to visit Eznews
India
World
Economy
Science
Health
Showbiz
Contact